- Home
- TNGX vs KIO Comparison
TNGX vs KIO Comparison
Compare TNGX & KIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNGX
- KIO
- Stock Information
- Founded
- TNGX 2014
- KIO 2011
- Country
- TNGX United States
- KIO United States
- Employees
- TNGX N/A
- KIO 2400
- Industry
- TNGX Biotechnology: Pharmaceutical Preparations
- KIO Investment Managers
- Sector
- TNGX Health Care
- KIO Finance
- Exchange
- TNGX Nasdaq
- KIO Nasdaq
- Market Cap
- TNGX 413.6M
- KIO 404.1M
- IPO Year
- TNGX N/A
- KIO N/A
- Fundamental
- Price
- TNGX $3.92
- KIO $13.32
- Analyst Decision
- TNGX Strong Buy
- KIO
- Analyst Count
- TNGX 8
- KIO 0
- Target Price
- TNGX $13.14
- KIO N/A
- AVG Volume (30 Days)
- TNGX 3.5M
- KIO 136.5K
- Earning Date
- TNGX 11-06-2024
- KIO 01-01-0001
- Dividend Yield
- TNGX N/A
- KIO 10.82%
- EPS Growth
- TNGX N/A
- KIO N/A
- EPS
- TNGX N/A
- KIO N/A
- Revenue
- TNGX $43,383,000.00
- KIO N/A
- Revenue This Year
- TNGX $25.55
- KIO N/A
- Revenue Next Year
- TNGX N/A
- KIO N/A
- P/E Ratio
- TNGX N/A
- KIO N/A
- Revenue Growth
- TNGX 15.67
- KIO N/A
- 52 Week Low
- TNGX $2.70
- KIO $10.52
- 52 Week High
- TNGX $13.01
- KIO $13.59
- Technical
- Relative Strength Index (RSI)
- TNGX 39.26
- KIO 30.38
- Support Level
- TNGX $3.54
- KIO $13.04
- Resistance Level
- TNGX $4.22
- KIO $13.49
- Average True Range (ATR)
- TNGX 0.53
- KIO 0.16
- MACD
- TNGX 0.13
- KIO 0.00
- Stochastic Oscillator
- TNGX 48.61
- KIO 33.73
About TNGX Tango Therapeutics Inc.
Tango Therapeutics Inc is a biotechnology company. It is dedicated towards discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. Its program TNG908, is an MTA-cooperative inhibitor of PRMT5 designed to work selectively in cancer cells with an MTAP deletion. Its pipeline further consists of discovery programs such as, TNG462, TNG348, TNG260 and others for multiple cancer types with limited treatment options.
About KIO KKR Income Opportunities Fund
KKR Income Opportunities Fund operates as a closed-end registered management investment company. It seeks to generate a high level of current income, with a secondary objective of capital appreciation. The company invests in the portfolio of loans and fixed-income instruments of U.S. and non-U.S. issuers. The company will invest at least 80% of its Managed Assets in loans and fixed-income instruments or other instruments, including derivative instruments, with similar economic characteristics under normal market conditions.